•
Jun 30, 2022

REGENXBIO Q2 2022 Earnings Report

Total Revenue
$32.6M
Previous year: $22M
+48.2%
EPS
-$1.58
Previous year: -$1.36
+16.2%
Gross Profit
$19.7M
Previous year: $12.2M
+61.2%
Cash and Equivalents
$121M
Previous year: $257M
-52.8%
Free Cash Flow
-$71M
Previous year: -$46.8M
+51.7%
Total Assets
$953M
Previous year: $836M
+14.0%

REGENXBIO

REGENXBIO